Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.
Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disorder of neuromuscular transmission in which antibodies are directed against voltage-gated calcium channels (VGCCs). We studied the action of LEMS immunoglobulin G (IgG) on cloned human VGCCs stably transfected into human embryonic kidney...
Príomhchruthaitheoirí: | Lang, B, Pinto, A, Giovannini, F, Newsom-Davis, J, Vincent, A |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
2003
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
de réir: Bain, P, et al.
Foilsithe / Cruthaithe: (1996) -
Autoantibodies in the Lambert-Eaton myasthenic syndrome (LEMS) and amyotrophic lateral sclerosis (ALS)
de réir: Lang, B
Foilsithe / Cruthaithe: (2007) -
Autoantibodies in the Lambert-Eaton Myasthenic Syndrome (LEMS) and Amyotrophic Lateral Sclerosis (ALS)
de réir: Lang, B, et al.
Foilsithe / Cruthaithe: (2013) -
Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
de réir: Motomura, M, et al.
Foilsithe / Cruthaithe: (1997) -
Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer.
de réir: Maddison, P, et al.
Foilsithe / Cruthaithe: (2001)